T-DM1 reduces long-term risk of death in HER2-positive breast cancer patients
In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive disease by 46% and ...
American Cancer Society7h
Cancer Incidence Rate for Women Under 50 Rises Above Men's
Cancer incidence continues to rise for many common cancers—especially for women. The incidence rate for women younger than 50 ...
emjreviews.com9h
Melanoma Tumours Thicker Than 0.8mm Increase Risk for Death
A study reveals that melanomas thicker than 0.8 mm are associated with a higher risk of melanoma-related death, highlighting ...